2 mg ETH267
Pill imprint 2 mg ETH267 has been identified as Doxazosin mesylate 2 mg.
Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy.
Doxazosin 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Doxazosin mesylate Images
- Imprint:
-
2 mg
ETH267 - Strength:
- 2 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate
D&C Yellow No. 10 Aluminium Lake
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0267
| NDC Code | Manufacturer / Repackager |
|---|---|
| 67253-0381 | DAVA Pharmaceuticals, Inc. |
| 54569-5169 | A S Medication Solutions LLC (repackager) |
| 58016-0997 | Southwood Pharmaceuticals Inc (repackager) |
| 33358-0116 | Core Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Doxazosin Mesylate resources
- Doxazosin
- Doxazosin (Wolters Kluwer)
- Doxazosin Extended-Release Tablets (Wolters Kluwer)
- doxazosin (Cerner Multum)
- doxazosin (Micromedex) - Includes Dosage Information
- Doxazosin Mesylate (AHFS DI)
- Doxazosin (FDA)
- Doxazosin Mesylate (Wolters Kluwer)
Search Again
